pd 142893 has been researched along with lisinopril in 1 studies
| Studies (pd 142893) | Trials (pd 142893) | Recent Studies (post-2010) (pd 142893) | Studies (lisinopril) | Trials (lisinopril) | Recent Studies (post-2010) (lisinopril) |
|---|---|---|---|---|---|
| 64 | 0 | 3 | 2,210 | 648 | 491 |
| Protein | Taxonomy | pd 142893 (IC50) | lisinopril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.0021 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.287 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benigni, A; Bertani, T; Brena, C; Bruzzi, I; Colosio, V; Remuzzi, G | 1 |
1 other study(ies) available for pd 142893 and lisinopril
| Article | Year |
|---|---|
Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cohort Studies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Follow-Up Studies; In Situ Hybridization; Kidney; Lisinopril; Male; Oligopeptides; Pilot Projects; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 1998 |